Amgen Patent Case Raises Questions About Drug Patent Application Purchases and Monopoly Extension
Source Summary
A drug patent case involving Amgen is being closely watched for its potential implications across the pharmaceutical industry. The case examines whether purchasing a drug patent application can constitute an attempt to prolong market monopoly.
Why it matters
The outcome could establish precedent for how pharmaceutical companies may or may not use patent acquisitions to extend market exclusivity.
